Cargando…
Quality of Life Assessment in Multiple Myeloma Patients Undergoing Dose-Reduced Tandem Autologous Stem Cell Transplantation
Few studies exist that consider health-related quality of life (HR-QoL) in patients with multiple myeloma (MM) undergoing tandem autologous stem cell transplantation (TASCT). Eighteen patients with advanced MM who underwent dose-modified TASCT were enrolled in this study between March 2006 and March...
Autores principales: | Khalafallah, A., McDonnell, K., Dawar, H.U., Robertson, I., Woods, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248334/ https://www.ncbi.nlm.nih.gov/pubmed/22220254 http://dx.doi.org/10.4084/MJHID.2011.057 |
Ejemplares similares
-
Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012) -
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
por: Naithani, Rahul, et al.
Publicado: (2020) -
Effect of Immunoglobulin Therapy on the Rate of Infections in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation or Treated with Immunomodulatory Agents.
por: Khalafallah, Alhossain, et al.
Publicado: (2010) -
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
por: Srour, Samer A., et al.
Publicado: (2021) -
Efficacy and safety of tandem autologous stem cell transplantation in multiple myeloma: a retrospective single-center analysis
por: Wu, Shunquan, et al.
Publicado: (2023)